243 related articles for article (PubMed ID: 11713593)
1. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
Williams CL; Noti JD
Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
[TBL] [Abstract][Full Text] [Related]
2. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
Chen RH; Ding WV; McCormick F
J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5.
Carey I; Williams CL; Ways DK; Noti JD
Int J Oncol; 1999 Jul; 15(1):127-36. PubMed ID: 10375605
[TBL] [Abstract][Full Text] [Related]
5. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
Yuan H; Mao J; Li L; Wu D
J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
Orme MH; Giannini AL; Vivanco MD; Kypta RM
Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
[TBL] [Abstract][Full Text] [Related]
8. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes.
Papkoff J; Rubinfeld B; Schryver B; Polakis P
Mol Cell Biol; 1996 May; 16(5):2128-34. PubMed ID: 8628279
[TBL] [Abstract][Full Text] [Related]
9. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
10. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene.
Ziemer LT; Pennica D; Levine AJ
Mol Cell Biol; 2001 Jan; 21(2):562-74. PubMed ID: 11134343
[TBL] [Abstract][Full Text] [Related]
11. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
Ways DK; Kukoly CA; deVente J; Hooker JL; Bryant WO; Posekany KJ; Fletcher DJ; Cook PP; Parker PJ
J Clin Invest; 1995 Apr; 95(4):1906-15. PubMed ID: 7706498
[TBL] [Abstract][Full Text] [Related]
12. Wnt-independent beta-catenin transactivation in tumor development.
Lu Z; Hunter T
Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
[TBL] [Abstract][Full Text] [Related]
13. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
14. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
15. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
16. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
17. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
18. Requirement of protein kinase Calpha, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorbeta-regulated expression of E-cadherin and catenins.
Wang H; Chakrabarty S
J Cell Physiol; 2001 May; 187(2):188-95. PubMed ID: 11267998
[TBL] [Abstract][Full Text] [Related]
19. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
Staal FJ; Burgering BM; van de Wetering M; Clevers HC
Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells.
Thievessen I; Seifert HH; Swiatkowski S; Florl AR; Schulz WA
Br J Cancer; 2003 Jun; 88(12):1932-8. PubMed ID: 12799639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
